Evidence map›Paper›PMID 39702306›Full record

ArticleNature communications2024

Unveiling the power of high-dimensional cytometry data with cyCONDOR.

Charlotte Kröger, Sophie Müller, Jacqueline Leidner, Theresa Kröber, Stefanie Warnat-Herresthal, Jannis Bastian Spintge, Timo Zajac, Anna Neubauer, Aleksej Frolov, Caterina Carraro and 8 more

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Charlotte Kröger *Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0000-0002-6627-3728
Sophie Müller *Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0000-0002-9885-4850
Jacqueline Leidner *Systems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0009-0004-7159-4667
Theresa KröberSystems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0009-0003-0034-9712
Stefanie Warnat-HerresthalSystems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Jannis Bastian SpintgeSystems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Timo ZajacSystems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Anna NeubauerSystems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Aleksej FrolovSystems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.
Caterina CarraroSystems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0000-0002-3039-4675
DELCODE Study Group
Frank JessenGerman Center for Neurodegenerative Diseases (DZNE), Bonn, Venusberg-Campus 1, Bonn, Germany.
Simone PuccioLaboratory of Translational Immunology, IRCCS Humanitas Research Hospital, via Manzoni 56, Rozzano, Milan, Italy.ORCID 0000-0003-4007-4365
Anna C AschenbrennerSystems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0000-0002-9429-5457
Joachim L SchultzeSystems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0000-0003-2812-9853
Tal PechtSystems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0000-0002-6442-0560
Marc D BeyerSystems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany.ORCID 0000-0001-9704-148X
Lorenzo BonaguroSystems Medicine, German Center for Neurodegenerative Diseases (DZNE), Bonn, Germany. lorenzobonaguro@uni-bonn.de.ORCID 0000-0001-9675-7208

Funding

Bundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01EA1809ABundesministerium für Bildung und Forschung (Federal Ministry of Education and Research) 01EJ2204DDeutsche Forschungsgemeinschaft (German Research Foundation) 01ZX1902BDeutsche Forschungsgemeinschaft (German Research Foundation) 272482170Deutsche Forschungsgemeinschaft (German Research Foundation) 390873048Deutsche Forschungsgemeinschaft (German Research Foundation) 432325352Deutsche Forschungsgemeinschaft (German Research Foundation) 432325352, 458854699, 466168337, 466168626Deutsche Forschungsgemeinschaft (German Research Foundation) 513977171EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 101057775EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 733100EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 847422EC | Horizon 2020 Framework Programme (EU Framework Programme for Research and Innovation H2020) 874656Else Kröner-Fresenius-Stiftung (Else Kroner-Fresenius Foundation) 2018_A158
6 · The paper itself

Abstract

High-dimensional cytometry (HDC) is a powerful technology for studying single-cell phenotypes in complex biological systems. Although technological developments and affordability have made HDC broadly available in recent years, technological advances were not coupled with an adequate development of analytical methods that can take full advantage of the complex data generated. While several analytical platforms and bioinformatics tools have become available for the analysis of HDC data, these are either web-hosted with limited scalability or designed for expert computational biologists, making their use unapproachable for wet lab scientists. Additionally, end-to-end HDC data analysis is further hampered due to missing unified analytical ecosystems, requiring researchers to navigate multiple platforms and software packages to complete the analysis. To bridge this data analysis gap in HDC we develop cyCONDOR, an easy-to-use computational framework covering not only all essential steps of cytometry data analysis but also including an array of downstream functions and tools to expand the biological interpretation of the data. The comprehensive suite of features of cyCONDOR, including guided pre-processing, clustering, dimensionality reduction, and machine learning algorithms, facilitates the seamless integration of cyCONDOR into clinically relevant settings, where scalability and disease classification are paramount for the widespread adoption of HDC in clinical practice. Additionally, the advanced analytical features of cyCONDOR, such as pseudotime analysis and batch integration, provide researchers with the tools to extract deeper insights from their data. We use cyCONDOR on a variety of data from different tissues and technologies demonstrating its versatility to assist the analysis of high-dimensional data from preprocessing to biological interpretation.

Indexed as

Computational BiologyFlow CytometrySoftwareAlgorithmsAnimalsCluster AnalysisHumansMachine LearningMiceSingle-Cell Analysis

Identifiers

PMID39702306
PMCPMC11659560

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.